(Q47948152)

English

A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children

scientific article published in September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12718836

A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12718836

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Li-Min Huang

5

0 references

object named as

Chin-Yun Lee

1

0 references

author name string

Ren-Bin Tang

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12718836

Fu-Yuan Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12718836

Haiwen Tang

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12718836

Hans L Bock

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12718836

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12718836

International Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12718836

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12718836

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12718836

202-209

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12718836

Effect of monovalent measles and trivalent measles-mumps-rubella vaccines at various ages and concurrent administration with hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Variations of nucleotide sequences and transcription of the SH gene among mumps virus strains

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Methods for screening the naturally acquired and vaccine-induced immunity to the mumps virus

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse events associated with MMR vaccines in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Measles antibody: reevaluation of protective titers

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rubella immunity. Defining the level of protective antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ender's live measles-virus vaccine with human immune globulin. II. Evaluation of efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990112-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1201-9712(02)90112-8

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12718836

release_ekwpv2wxprejxp5ra5c7o4dpve

1 reference

https://api.fatcat.wiki/v0/release/ekwpv2wxprejxp5ra5c7o4dpve

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12718836

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47948152&oldid=2176644572"